Table of Content
CAR-T Cell Therapy, or Chimeric Antigen Receptor T-Cell Therapy, is an advanced form of immunotherapy used primarily for treating certain blood cancers, such as leukemia and lymphoma. The treatment involves collecting a patient's T-cells, genetically modifying them to better target cancer cells, and then reinfusing them into the patient. These engineered T-cells are designed to seek out and destroy cancerous cells in the body. CAR-T therapy has shown promising results in patients who have not responded well to other forms of cancer treatment.
Treatment Type | Description |
---|---|
Standard CAR-T Therapy | Uses patient's T-cells engineered to attack cancer cells with a specific target antigen. |
Allogeneic CAR-T Therapy | Utilizes T-cells from a healthy donor, offering an alternative for patients unable to use their own cells. |
To find out Different Packages for CAR-T Cell Therapy, Click here.
The CAR-T Cell Therapy procedure typically involves the following steps:
Step | Description |
---|---|
1 | Collection of T-cells from the patient's blood through a process called leukapheresis. |
2 | Genetic modification of T-cells in a laboratory to create CAR-T cells capable of targeting cancer cells. |
3 | Multiplication of CAR-T cells to ensure sufficient quantity for effective treatment. |
4 | Reinfusion of CAR-T cells into the patient, followed by close monitoring for side effects. |
Country | Estimated Cost (USD) |
---|---|
Mexico | $25,000 - $35,000 |
Turkey | $30,000 - $40,000 |
Thailand | $32,000 - $45,000 |
Colombia | $28,000 - $38,000 |
India | $20,000 - $30,000 |
Austria | $45,000 - $60,000 |
USA | $90,000 - $120,000 |
UK | $80,000 - $110,000 |
Find Prices for CAR-T Cell Therapy Near You: Click here.
The cost of CAR-T Cell Therapy without insurance can range from $20,000 to $120,000, depending on the country and clinic. More affordable options are available in countries like India and Mexico compared to the U.S. or the U.K.
CAR-T Cell Therapy has been highly effective in treating certain types of blood cancers, especially for patients who have not responded to other treatments. However, effectiveness varies based on the type and stage of cancer.
Most patients begin to see results within a few weeks of treatment, but full recovery and effectiveness can vary depending on individual health conditions and response to therapy.
Possible side effects include cytokine release syndrome (CRS), neurological symptoms, fever, and risk of infection. Proper medical care is crucial to managing these side effects.
No, CAR-T Cell Therapy is primarily used for certain types of blood cancers. Not all patients qualify, and eligibility is determined based on the patient's health status and cancer type.
Are you considering CAR-T Cell Therapy as your next step in fighting cancer? PlacidWay connects you with leading clinics offering CAR-T Cell Therapy abroad. With expert medical teams and affordable treatment options, we strive to help you on your path to better health. Contact us now to learn more and schedule your consultation. Let PlacidWay support you in this crucial journey towards recovery and hope!
Stem Cell Therapy Abroad